Financials

News Discussions Technicals Forecast Seasonals

Net income before discontinued operations of Context Therapeutics Inc.

Annual data

2020

2021

2022

2023

TTM

‪‪−33.00 M‬‬

‪‪−22.00 M‬‬

‪‪−11.00 M‬‬

‪0.00‬

‪‪11.00 M‬‬

Period

Value

Change

Change %

TTM

‪‪−30.15 M‬‬

‪‪−6.19 M‬‬

‪−25.82‬%

2023

‪‪−23.96 M‬‬

‪‪−9.13 M‬‬

‪−61.53‬%

2022

‪‪−14.84 M‬‬

‪‪−4.38 M‬‬

‪−41.88‬%

2021

‪‪−10.46 M‬‬

‪‪−17.10 M‬‬

‪−257.38‬%

2020

‪‪6.64 M‬‬

+‪‪13.03 M‬‬

—

Quarterly data

Q2 '20

Q3 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−20.00 M‬‬

‪‪−15.00 M‬‬

‪‪−10.00 M‬‬

‪‪−5.00 M‬‬

‪0.00‬

Period

Value

Change

Change %

Q3 '24

‪‪−17.46 M‬‬

‪‪−15.21 M‬‬

‪−674.44‬%

Q2 '24

‪‪−2.25 M‬‬

+‪‪1.41 M‬‬

+‪38.53‬%

Q1 '24

‪‪−3.67 M‬‬

+‪‪3.10 M‬‬

+‪45.82‬%

Q4 '23

‪‪−6.77 M‬‬

‪‪−895.20 K‬‬

‪−15.24‬%

Q3 '23

‪‪−5.87 M‬‬

‪‪−863.37 K‬‬

‪−17.23‬%

Q2 '23

‪‪−5.01 M‬‬

+‪‪1.30 M‬‬

+‪20.56‬%

Q1 '23

‪‪−6.31 M‬‬

‪‪−2.75 M‬‬

‪−77.36‬%

Q4 '22

‪‪−3.56 M‬‬

+‪‪297.53 K‬‬

+‪7.72‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q3 '20

Q2 '20